By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix said this week that it has released eBioscience from certain obligations under the terms of their proposed merger as the Santa Clara, Calif.-based array firm continues in its efforts to salvage the $330 million deal.

The company also disclosed a deal with a firm named Cellular Research, founded by Stephen Fodor, who also founded Affy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.